Bob Lay New COO of AlloSource

Bob Lay, a professional with over 20 years of experience in finance and operations, is the new Chief Operating Officer of AlloSource.

“The Chief Operating Officer role at AlloSource is critical to creating the cellular and tissue products surgeons need to help restore mobility in more patients,” said Thomas Cycyota, AlloSource president and chief executive officer, in the November 7, 2017 news release. “Bob’s background, as well as his open-minded approach to driving improvements, will help us identify new opportunities to advance the work we do.”

As the company wrote in its news release, “In addition to his role as Chief Operating Officer, Bob also served AlloSource as the Director of Cost Accounting and Vice President, Operations. Prior to his time at AlloSource, he held leadership roles at both startups and large companies. Bob received his Bachelor’s and Master’s degrees in Accounting from the University of Denver.”

Bob Lay told OTW, “One of the most important parts of this role is understanding the impact of operations both internally and externally. The way our operations team integrates with each department to positively impact customers and patients is critical. In addition to roles with both large and small organizations, I previously served in a director role for a multinational medical device company and was involved in both finance and operations. Having that balance helps provide a unique perspective on the impact each department has on an organization and on our customers.”

“Since I came to AlloSource, I’ve been impressed by the passion of the operations team and their dedication to honoring the gift of tissue donation, taking extraordinary steps to help patients heal and return to full, active lives. As one of the nation’s leaders in regenerative medicine therapies, we will continue to identify and capitalize on new opportunities to grow our organization and, most importantly, to impact the lives of patients every day.”